Simethicone antacid lozenge

Details Simethicone antacid lozenge Simethicone antacid lozenge

1982-05-17

1983-08-02

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Monoclonal antibody or fragment thereof

424155, 424156, 424157, 424184, 424317, A61K 31695, A61K 3119, A61K 3306, A61K 3312, A61K 3310, A61K 3308

Patent

active

043966047

ABSTRACT:
Provided is a method and lozenge composition which permits antacid and simethicone to be in intimate contact while still maintaining unimpaired defoaming activity of simethicone.

REFERENCES:
patent: 2926121 (1960-02-01), Hobbs et al.
patent: 2934472 (1960-04-01), May
patent: 2951011 (1960-08-01), Feinstone
patent: 3382150 (1968-05-01), Grass et al.
patent: 3422189 (1969-01-01), Rider
patent: 3501571 (1970-05-01), Yen
patent: 3767794 (1973-10-01), McVean et al.
patent: 4127650 (1978-11-01), Buehler
patent: 4163777 (1979-08-01), Mitra
patent: 4198390 (1980-04-01), Rider
Handbook of Nonprescription Drugs, 5th ed., pp. 13-17.

Affiliated with

Also associated with

Rating

Simethicone antacid lozenge does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Simethicone antacid lozenge, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Simethicone antacid lozenge will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-483721